SCHEMBL3075326

SCHEMBL3075326

CCC(=O)NC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7131964 0.97
Butane SCHEMBL27571304 0.95 CRBN (0.43)
SCHEMBL27812076 0.90 CRBN (0.40)
SCHEMBL389017 0.81
Propionamide SCHEMBL27771596 0.79 CRBN (0.40)
SCHEMBL1070815 0.78
SCHEMBL169830 0.78
SCHEMBL4879049 0.78
Alcohol SCHEMBL28816200 0.78 CRBN (0.43)
SCHEMBL26707578 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118844429-A Protein-based agricultural chemical with reduced and enhanced efficacy 陕西师范大学 2024-10-29 CN claimed
CN-115537793-A Chromium-free passivation sealing treatment method for galvanized steel sheet 安徽舜邦精细化工有限公司 2022-12-30 CN claimed
US-20060154926-A1 Methods of treating alzheimer's disease using aryl alkanoic acid amides ELAN PHARMACEUTICALS, INC. 2006-07-13 US claimed
EP-0678503-B1 Delta-amino-gamma-hydroxy-omega-aryl alkanoic acid amides with enzyme especially renin inhibiting activities NOVARTIS AG (CH) 1999-09-01 EP claimed
CN-85108111-B EPOXY RESIN COMPOSITION 三菱电机株式会社 1988-06-15 CN claimed
CN-85108111-A Composition epoxy resin 1986-08-13 CN claimed
US-4120980-A Protein-rich foodstuffs for ruminants VEBA CHEMIE AKTIENGESELLSCHAFT (DE) 1978-10-17 US claimed
US-20260146249-A1 ANTISENSE OLIGONUCLEOTIDES FOR TREATING A DISEASE OR CONDITION ASSOCIATED WITH AN ABNORMAL PROCESSING OF APP VICO THERAPEUTICS B.V. (NL) 2026-05-28 US disclosed
WO-2026099473-A1 OLIGONUCLEOTIDES WITH NEW INTERNUCLEOSIDE LINKAGE VICO THERAPEUTICS B.V. (NL) 2026-05-15 WO disclosed
US-12331293-B2 Bispecific antisense oligonucleotides for dystrophin exon skipping BIOMARIN TECHNOLOGIES B.V. (NL) 2025-06-17 US disclosed
EP-4562145-A1 ANTISENSE OLIGONUCLEOTIDES FOR TREATING A DISEASE OR CONDITION ASSOCIATED WITH AN ABNORMAL PROCESSING OF APP Vico Therapeutics B.V. (NL) 2025-06-04 EP disclosed
EP-4519437-A2 OLIGONUCLEOTIDE Academisch Ziekenhuis Leiden (h.o.d.n. LUMC) (NL) 2025-03-12 EP disclosed
US-20250011784-A1 RNA MODULATING OLIGONUCLEOTIDES WITH IMPROVED CHARACTERISTICS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS VICO THERAPEUTICS B V (NL) 2025-01-09 US disclosed
CN-1070925-A Molecular weight is less than the solids composition of 1500 multi-shrinking glyceryl compound CIBA GEIGY AG (CH) 1993-04-14 CN disclosed
EP-0503471-A1 Acylaminosubstituted hetrazepines BOEHRINGER INGELHEIM KG (DE) 1992-09-16 EP disclosed
US-5135949-A Anticoagulants BOEHRINGER MANNHEIM GMBH (DE) 1992-08-04 US disclosed
CN-1047324-A The propylene ester adhesive composition that contains linking agent and impact modifying agent ROHM & HAAS (US) 1990-11-28 CN disclosed
CN-1035113-A The heterogeneous ring compound that is used for the treatment of WELLCOME FOUND (GB) 1989-08-30 CN disclosed
CN-1034722-A Triazole [4,3-a] [1,4] benzodiazepines and thieno-[3,2-f] [1,2,4] triazolo [4,3-a] [1,4] diazepine HOFFMANN LA ROCHE (CH) 1989-08-16 CN disclosed
US-4120980-A Protein-rich foodstuffs for ruminants VEBA CHEMIE AKTIENGESELLSCHAFT (DE) 1978-10-17 US disclosed